Cardiac Myosin Inhibitors: Unlocking Potential to Improve Treatment in Hypertrophic Cardiomyopathy

Circulation. 2023 Feb 28;147(9):700-702. doi: 10.1161/CIRCULATIONAHA.122.061015. Epub 2023 Feb 27.

Authors

Aslan Teyfik Turer¹, Andrew Wang²

Affiliations

¹ From the Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (A.T.T.).
² Department of Internal Medicine, Division of Cardiology, Duke University, Durham, NC (A.W.).

PMID: 36848411
DOI: 10.1161/CIRCULATIONAHA.122.061015

No abstract available

Keywords: cardiac myosins; cardiomyopathy, hypertrophic; drug therapy; pharmacologic actions.

MeSH terms

Cardiomyopathy, Hypertrophic* / drug therapy
Humans
Myosins* / antagonists & inhibitors

Substances

Myosins